Menu
Back to Journals » Journal of Asthma and Allergy » Volume 2
Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
Authors Nettis E, Calogiuri G, Di Leo E, Cardinale F, Macchia L, Ferrannini A, Vacca A
Published 16 December 2008 Volume 2009:2 Pages 17—23
DOI https://doi.org/10.2147/JAA.S3022
Review by Single anonymous peer review
Peer reviewer comments 2
E Nettis1, G F Calogiuri2, E Di Leo1, F Cardinale3, L Macchia1, A Ferrannini1, A Vacca1,4
1Section of Allergology and Clinical Immunology, Department of Internal Medicine and Infectious Diseases; 24th Pneumology Department, Pneumologic Hospital A Galateo, San Cesario di Lecce, Italy; 3Department of Biomedicina dell’Età Evolutiva, Pediatrics Unit “S Maggiore”; 4Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy
Abstract: Levocetirizine is the pharmacologically active enantiomer of cetirizine. It is a potent histamine H-1 receptor antagonist with anti-inflammatory and antiallergic properties. The review analyses the levocetirizine’s properties in terms of safety and efficacy both in allergic rhinitis and urticarioid syndromes.
Keywords: allergic rhinitis, chronic idiopatic urticaria, levocetirizine
© 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.